Home Healthcare Biotechnology Solid Tumor Testing Market

Solid Tumor Testing Market Size, Share & Trends Analysis Report By Type (Genetic testing, Conventional testing), By Cancer Type (Breast Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Cervical Cancer), By End-User (Hospitals, Pharmaceutical and biotechnology companies, Contract research organizations, Academic research institutions) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: May 25, 2026 | Author: Jay Mehta | Format:
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Solid Tumor Testing Market, By Type 2022-2034 (USD MILLION/ Units)
    1. Genetic testing
    2. Conventional testing
  2. Solid Tumor Testing Market, By Cancer Type 2022-2034 (USD MILLION/ Units)
    1. Breast Cancer
    2. Lung Cancer
    3. Colorectal Cancer
    4. Prostate Cancer
    5. Cervical Cancer
  3. Solid Tumor Testing Market, By End-User  2022-2034 (USD MILLION/ Units)
    1. Hospitals
    2. Pharmaceutical and biotechnology companies
    3. Contract research organizations
    4. Academic research institutions
  4. Regional Solid Tumor Testing Market
    1. North America
      1. North America Solid Tumor Testing Market By Type 2022-2034 (USD MILLION/ Units)
        1. Genetic testing
        2. Conventional testing
      2. North America Solid Tumor Testing Market By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Cervical Cancer
      3. North America Solid Tumor Testing Market By End-User  2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmaceutical and biotechnology companies
        3. Contract research organizations
        4. Academic research institutions
      4. U.S.
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      5. Canada
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
    2. Europe
      1. Europe Solid Tumor Testing Market By Type 2022-2034 (USD MILLION/ Units)
        1. Genetic testing
        2. Conventional testing
      2. Europe Solid Tumor Testing Market By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Cervical Cancer
      3. Europe Solid Tumor Testing Market By End-User  2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmaceutical and biotechnology companies
        3. Contract research organizations
        4. Academic research institutions
      4. U.K.
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      5. Germany
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      6. France
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      7. Spain
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      8. Italy
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      9. Russia
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      10. Nordic
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      11. Benelux
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      12. Rest of Europe
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
    3. APAC
      1. APAC Solid Tumor Testing Market By Type 2022-2034 (USD MILLION/ Units)
        1. Genetic testing
        2. Conventional testing
      2. APAC Solid Tumor Testing Market By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Cervical Cancer
      3. APAC Solid Tumor Testing Market By End-User  2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmaceutical and biotechnology companies
        3. Contract research organizations
        4. Academic research institutions
      4. China
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      5. Korea
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      6. Japan
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      7. India
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      8. Australia
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      9. Taiwan
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      10. South East Asia
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      11. Rest of Asia-Pacific
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
    4. Middle East and Africa
      1. Middle East and Africa Solid Tumor Testing Market By Type 2022-2034 (USD MILLION/ Units)
        1. Genetic testing
        2. Conventional testing
      2. Middle East and Africa Solid Tumor Testing Market By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Cervical Cancer
      3. Middle East and Africa Solid Tumor Testing Market By End-User  2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmaceutical and biotechnology companies
        3. Contract research organizations
        4. Academic research institutions
      4. UAE
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      5. Turkey
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      6. Saudi Arabia
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      7. South Africa
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      8. Egypt
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      9. Nigeria
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      10. Rest of MEA
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
    5. LATAM
      1. LATAM Solid Tumor Testing Market By Type 2022-2034 (USD MILLION/ Units)
        1. Genetic testing
        2. Conventional testing
      2. LATAM Solid Tumor Testing Market By Cancer Type 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Prostate Cancer
        5. Cervical Cancer
      3. LATAM Solid Tumor Testing Market By End-User  2022-2034 (USD MILLION/ Units)
        1. Hospitals
        2. Pharmaceutical and biotechnology companies
        3. Contract research organizations
        4. Academic research institutions
      4. Brazil
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      5. Mexico
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      6. Argentina
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      7. Chile
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      8. Colombia
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
      9. Rest of LATAM
        1. Genetic testing
        2. Conventional testing
        3. Breast Cancer
        4. Lung Cancer
        5. Colorectal Cancer
        6. Prostate Cancer
        7. Cervical Cancer
        8. Hospitals
        9. Pharmaceutical and biotechnology companies
        10. Contract research organizations
        11. Academic research institutions
Report Details
−
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.